Cure's recent performance against Protoss players shows a concerning 40% win rate over the last 10 matches, indicating a vulnerability that Zoun could exploit. Zoun, on the other hand, has been consistently dominating in the PvT matchup with an 80% win rate, which is a significant indicator of his confidence and adaptability in this series.

Cure has shown flashes of brilliance in his recent games but has been plagued by inconsistency, particularly in his late-game decision-making and unit composition. His reliance on standard tactics has been countered effectively by opponents who exploit his predictable playstyle. Meanwhile, Zoun has been on a hot streak, demonstrating exceptional control and clever harassment strategies that keep opponents on their toes. His adept use of Stalkers and Disruptors has proven pivotal in recent matches, making it difficult for Terran players to secure advantageous positions.

In terms of hero pool, Cure favors a bio-centric composition, but his execution often falters against well-timed Protoss tech switches. Zoun’s ability to transition into a high-tech army that includes Colossi and Archons can outmaneuver Cure's typical mid-game timing attacks. Zoun's adeptness at map control and expansion means he can dictate the pace of the game, forcing Cure to respond rather than initiate. Expect Zoun to leverage his map pool advantage, particularly on maps that favor blink micro and positional play, such as 'Lightshade' or 'Eternal Empire'.